Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Raw Materials (2019 - 2022)

Marimed has reported Raw Materials over the past 4 years, most recently at $2.4 million for Q1 2022.

  • Quarterly Raw Materials fell 35.03% to $2.4 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Mar 2022, down 35.03% year-over-year, with the annual reading at $1.0 million for FY2021, 475.6% up from the prior year.
  • Raw Materials was $2.4 million for Q1 2022 at Marimed, up from $1.0 million in the prior quarter.
  • Over five years, Raw Materials peaked at $3.7 million in Q1 2021 and troughed at $176338.0 in Q4 2020.
  • The 4-year median for Raw Materials is $1.0 million (2021), against an average of $1.6 million.
  • Year-over-year, Raw Materials soared 475.6% in 2021 and then tumbled 35.03% in 2022.
  • A 4-year view of Raw Materials shows it stood at $225620.0 in 2019, then decreased by 21.84% to $176338.0 in 2020, then soared by 475.6% to $1.0 million in 2021, then surged by 137.73% to $2.4 million in 2022.
  • Per Business Quant, the three most recent readings for MRMD's Raw Materials are $2.4 million (Q1 2022), $1.0 million (Q4 2021), and $256331.0 (Q3 2021).